Margaret Foti is the recipient of the 2024 Beacon Award for Women Leaders in Oncology
Established in 2022 by the AIM-HI Accelerator Fund and sponsored by the National Foundation for Cancer Research, The Beacon Award for Women Leaders in Oncology honors exceptional women leaders in health and life sciences. The award specifically acknowledges those who have made significant contributions to advancing cancer treatment, detection, and diagnosis on a global scale.
Margaret Foti, PhD, MD (hc) has been selected as the recipient of the 2024 Beacon Award for Women Leaders in Oncology.
Margaret Foti is the Chief Executive Officer of the American Association for Cancer Research (AACR). Starting her career at AACR as an editorial staff member for the journal Cancer Research, she advanced through various editorial and management positions.
Under her leadership, the AACR launched nine major peer-reviewed journals, including Cancer Discovery and Cancer Immunology Research. Her focused and visionary leadership drives the AACR’s mission to advance cancer research and work towards the prevention and cure of cancer.
On this occasion, AIM-HI Accelerator Fund shared a post on LinkedIn:
“The AIM-HI Accelerator Fund is thrilled to announce that Margaret Foti, Ph.D., M.D. (hc), Chief Executive Officer of the American Association for Cancer Research (AACR), is the recipient of the 2024 Beacon Award for Women Leaders in Oncology. Congratulations, Dr. Foti!
‘As the CEO and Co-Founder of the AIM-HI Accelerator Fund, CEO of the National Foundation for Cancer Research, I have the unique privilege to work alongside some of the most accomplished, innovative, and respected leaders in cancer research and the fields of oncology.
Dr. Foti epitomizes the attributes of impactful leadership and everything we at AIM-HI and NFCR seek to recognize in a Beacon Award recipient.
I have known of the unwavering work of Dr. Foti for many years and have high respect for the impacts she has made on cancer research, science, and patient care worldwide,’ said Dr. Sujuan Ba, PhD, President and CEO of the AIM-HI Accelerator Fund and National Foundation for Cancer Research and Co-Chair of the 2024 Beacon Award Selection Committee.
‘I am deeply honored to be named the 2024 Beacon Award for Women Leaders in Oncology recipient. This recognition is a testament to the relentless dedication and groundbreaking work of our members and entire team at AACR, as well as our partners in the cancer research community.
Together, we are committed to accelerating the pace of scientific discovery and translating these findings into effective treatments that improve the lives of patients worldwide. This award inspires us to continue pushing the boundaries of innovation and collaboration in our ongoing fight against cancer.
I would like to thank the Beacon Award Selection Committee and extend my heartfelt gratitude to AIM-HI Accelerator Fund and the National Foundation for Cancer Research for this prestigious acknowledgment and for their unwavering support of cancer research,’ said Margaret Foti, Ph.D., M.D. (h.c.), Chief Executive Officer of the American Association for Cancer Research.
Dr. Foti will be honored as the 2024 AIM-HI Beacon Award recipient at a luncheon ceremony at the National Press Club in Washington, DC, on October 18, 2024. The award ceremony is part of the 2024 Global Summit and Award Ceremonies for Cancer Research and Entrepreneurship.
2024 Beacon Award Selection Committee:
- Sujuan Ba, Ph.D., Co-Chair
- Webster Cavenee, Ph.D., Co-Chair
- Bahija Jallal, Ph.D.
- Raju Kucherlapati, Ph.D.
- Patricia Obermaier, MBA
- Libia F. Scheller, PhD, MBA
- Thea Tlsty, Ph.D.
The Past Beacon Award Recipients:
- Anna Barker, Ph.D., 2022 Awardee
- Monica Bertagnolli, M.D., 2023 Awardee
Read the Press Release.
Join us in honoring Dr. Margaret Foti.”
Source: AIM-HI Accelerator Fund/LinkedIn